linkedin.enzyme.finance
DNS Records
| A | 104.20.42.94 |
| A | 172.66.167.155 |
| AAAA | 2606:4700:10::6814:2a5e |
| AAAA | 2606:4700:10::ac42:a79b |
Affiliations
Subdomains
Social media
JSON+LD
{
"@context": "http://schema.org",
"@graph": [
{
"@context": "http://schema.org",
"@type": "DiscussionForumPosting",
"author": {
"@type": "Organization",
"name": "Enzyme",
"url": "https://www.linkedin.com/company/enzymefinance"
},
"datePublished": "2025-07-24T15:16:31.412Z",
"mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_dao-treasuries-meet-your-upgrade-enzyme-activity-7354167607471620096-p8Wl",
"text": "DAO treasuries, meet your upgrade.\n\nEnzyme lets DAOs take a hands-on approach to treasury management with non-custodial vaults and customizable permissions. Automate strategies, diversify holdings, and track every move all in real time, fully onchain. \n\nWith Enzyme, you can create treasury workflows tailored to your DAO, ensure secure multi-signature governance, and give your community on-demand reporting with transparent, auditable records.\n\nReady to put your idle assets to work and lead by example? \nLearn more: https://lnkd.in/dUcyhrpM ",
"url": "https://www.linkedin.com/posts/enzymefinance_dao-treasuries-meet-your-upgrade-enzyme-activity-7354167607471620096-p8Wl"
},
{
"@context": "http://schema.org",
"@type": "DiscussionForumPosting",
"author": {
"@type": "Organization",
"name": "Enzyme",
"url": "https://www.linkedin.com/company/enzymefinance"
},
"datePublished": "2025-07-22T17:32:28.075Z",
"mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_how-daos-are-running-recurring-options-strategies-activity-7353477043264647168-zsZw",
"text": "How DAOs are running recurring options strategies from their treasury vaults?\n\nWith Enzyme.Myso now integrated in Enzyme.Blue, DAOs can create a dedicated Options Vault to run recurring covered call or put strategies directly from their treasury.\n\nHow it works:\n• The DAO creates an Enzyme Vault on Enzyme.Blue, sets up permissions, and funds it with idle assets.\n• The vault is connected to Enzyme.Myso, which enables the DAO (or an assigned manager) to execute options trades on a recurring basis.\n• All trades, yields, and flows are fully auditable and visible to the DAO community.\n• Roles can be delegated or managed by the DAO’s own process.\n\nCase in point: Compound DAO’s options vault uses this structure to regularly sell covered calls, helping the DAO target yield, maintain transparency, and customize risk exposure.\n\nReady to see how Enzyme.Blue + Enzyme.Myso vaults could fit your treasury?\nLearn more: https://lnkd.in/gY7Mndcp",
"url": "https://www.linkedin.com/posts/enzymefinance_how-daos-are-running-recurring-options-strategies-activity-7353477043264647168-zsZw"
},
{
"@context": "http://schema.org",
"@type": "DiscussionForumPosting",
"author": {
"@type": "Organization",
"name": "Enzyme",
"url": "https://www.linkedin.com/company/enzymefinance"
},
"datePublished": "2025-07-20T12:51:08.139Z",
"mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_incredible-to-see-enzymemyso-v3-hit-40m-activity-7352681467916824576-ImFE",
"text": "Incredible to see Enzyme.Myso v3 hit $40M+ in notional settled this year, a record 8x growth in just three months! 🧬\n\nHuge thanks to our community, partners, and everyone exploring what’s possible with Enzyme.",
"url": "https://www.linkedin.com/posts/enzymefinance_incredible-to-see-enzymemyso-v3-hit-40m-activity-7352681467916824576-ImFE"
},
{
"@context": "http://schema.org",
"@type": "DiscussionForumPosting",
"author": {
"@type": "Organization",
"name": "Enzyme",
"url": "https://www.linkedin.com/company/enzymefinance"
},
"datePublished": "2025-07-17T14:35:00.598Z",
"headline": "",
"mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_looking-back-on-an-amazing-week-at-ethcc-activity-7351620445156126720-LCMm",
"text": "Looking back on an amazing week at EthCC: Cannes, community, and so many good moments. Watch the highlights from an unforgettable week 👇",
"url": "https://www.linkedin.com/posts/enzymefinance_looking-back-on-an-amazing-week-at-ethcc-activity-7351620445156126720-LCMm"
},
{
"@context": "http://schema.org",
"@type": "DiscussionForumPosting",
"author": {
"@type": "Organization",
"name": "Enzyme",
"url": "https://www.linkedin.com/company/enzymefinance"
},
"datePublished": "2025-07-15T14:04:55.782Z",
"mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_why-daos-are-turning-to-structured-products-activity-7350888099482107904-d_Zb",
"text": "Why DAOs are turning to structured products for treasury efficiency?\n\nThe treasury conversation inside DAOs is shifting. It’s no longer just about “how do we earn yield?” Now, they are thinking about how to put idle assets to work strategically, with clear rules, minimized risk, and full on-chain transparency.\n\nHere are the reasons why structured products (especially covered calls and puts) are gaining traction with DAO treasuries in 2025:\n\n• Clarity: Structured options strategies let treasury managers define specific objectives for return, risk, and asset allocation just as in traditional finance. The key difference? Now these outcomes are encoded and executed onchain, offering both customization and transparency for DAOs and their communities.\n• Capital Efficiency: Covered calls and cash-secured puts enable DAOs to generate yield on assets that would otherwise sit idle, without taking on unnecessary protocol risk.\n• Risk Management: Options-based strategies allow DAOs to monetize volatility or set explicit downside floors. This helps DAOs preserve runway and govern with prudence even in unpredictable markets.\n\nEnzyme.Myso is at the forefront of this trend by giving DAOs programmable, natively onchain tools to design, execute, and monitor these strategies with full flexibility and auditability.\n\nReady to unlock smarter treasury strategies? Learn more: https://lnkd.in/dDC9C3c8",
"url": "https://www.linkedin.com/posts/enzymefinance_why-daos-are-turning-to-structured-products-activity-7350888099482107904-d_Zb"
},
{
"@context": "http://schema.org",
"@type": "DiscussionForumPosting",
"author": {
"@type": "Organization",
"name": "Enzyme",
"url": "https://www.linkedin.com/company/enzymefinance"
},
"datePublished": "2025-07-13T11:06:57.249Z",
"mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_onchain-options-are-becoming-a-way-to-make-activity-7350118534733090816-UZdU",
"text": "Onchain options are becoming a way to make treasuries work harder. Here’s an example 👇\n\nCompound Labs DAO recently demonstrated a sophisticated approach by integrating covered calls into their treasury strategy using Enzyme.Myso, targeting a ~15% APY.\n\nThe objective is simple: put idle assets to work without overextending risk exposure.\n\nIt’s a compelling example of how DAOs are starting to use options to manage idle capital and optimize returns with defined risk.\n\nEnzyme.Myso makes this possible:\n▫️ Natively onchain options strategies\n▫️ Fully auditable flows\n▫️ Designed for DAOs and institutions\n\nAs derivatives infrastructure matures, use cases like this point to where DeFi is going next. \n\nLearn more about Enzyme.Myso: https://lnkd.in/dDC9C3c8",
"url": "https://www.linkedin.com/posts/enzymefinance_onchain-options-are-becoming-a-way-to-make-activity-7350118534733090816-UZdU"
},
{
"@context": "http://schema.org",
"@type": "DiscussionForumPosting",
"author": {
"@type": "Organization",
"name": "Enzyme",
"url": "https://www.linkedin.com/company/enzymefinance"
},
"datePublished": "2025-07-09T17:11:41.775Z",
"mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_another-milestone-for-enzymemyso-after-activity-7348760773617201153-xTRt",
"text": "Another milestone for Enzyme.Myso - After crossing $20M in notional just weeks ago, we’ve now reached $1.20M+ in premiums 📈\n\nHere’s where we stand today:\n• $1.20M+ in total premiums\n• $33M+ in notional volume\n• 7× growth over the past 90 days\n\nAs demand for structured strategies accelerates, Enzyme.Myso is becoming the go-to execution layer for tokenized options and yield. Explore: https://lnkd.in/dDC9C3c8",
"url": "https://www.linkedin.com/posts/enzymefinance_another-milestone-for-enzymemyso-after-activity-7348760773617201153-xTRt"
},
{
"@context": "http://schema.org",
"@type": "DiscussionForumPosting",
"author": {
"@type": "Organization",
"name": "Enzyme",
"url": "https://www.linkedin.com/company/enzymefinance"
},
"datePublished": "2025-07-08T13:58:13.953Z",
"mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_why-defi-derivatives-volumes-are-surging-activity-7348349698992214017-cIFK",
"text": "Why DeFi derivatives volumes are surging, and what that tells us about market maturity? A general outlook ⬇️\n\nA quiet but meaningful shift is underway in crypto markets: decentralized derivatives are scaling.\n\nPerpetual DEXs are gaining traction at institutional scale. In June, decentralized futures volume reached 8% of all CEX futures volume according to The Block. That’s up from 6.8% in May and 4.8% this time last year.\n\nThe signal is clear: DeFi-native derivatives are no longer speculative side bets. They’re becoming a core part of onchain portfolio construction.\n\nAnd institutions are responding. The $2.9B acquisition of Deribit by Coinbase is an infrastructure play. Deribit processed $1.2T in options volume last year. Bringing that under a regulated umbrella points to the convergence that’s defining this cycle: onchain rails powering institutional-grade instruments.\n\nThis moment matters. Derivatives are foundational to modern markets, essential for hedging, liquidity, and capital efficiency. As DeFi protocols evolve to offer structured, risk-adjusted strategies built on options, it unlocks a new layer of composability and control.\n\nThe first wave of DeFi brought spot markets onchain. The next wave is about instruments, and derivatives are leading the charge.\n\nEnzyme is already building for this future through Enzyme.Myso: a protocol for onchain structured products and natively tokenized options.\n\nThis is where infrastructure meets innovation. Learn more: https://lnkd.in/dDC9C3c8",
"url": "https://www.linkedin.com/posts/enzymefinance_why-defi-derivatives-volumes-are-surging-activity-7348349698992214017-cIFK"
},
{
"@context": "http://schema.org",
"@type": "DiscussionForumPosting",
"author": {
"@type": "Organization",
"name": "Enzyme",
"url": "https://www.linkedin.com/company/enzymefinance"
},
"datePublished": "2025-07-04T12:20:04.060Z",
"mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_back-from-ethcc-and-still-thinking-about-activity-7346875443519590402-YC1H",
"text": "Back from EthCC, and still thinking about everything we saw in Cannes 👀\n\nIt’s been one of the most vibrant editions yet. Here are some of the key takeaways:\n\n・Institutions are here: For the first time, the institutional presence was unmissable, a strong signal that the onchain shift is well underway.\n・Stablecoins front and center: From unlocking yield to improving payment rails, stablecoins were a major talking point across panels and side events.\n・RWAs stole the show: Robinhood’s announcement made waves, and it strengthened the attention to the broader shift: real-world assets are becoming core to the crypto conversation.\n・Builders > hype: Big names like Arbitrum were still in the spotlight, but this year felt more grounded, less narrative-chasing, more product-first progress.\n\nFor Enzyme, Cannes delivered.\n\n・Enzyme.Onyx was a standout. More builders are searching for ways to deploy flexible, cross-chain tokenized strategies. Onyx is fast becoming the go-to tool for just that.\n・Beyond RWAs and tokenized funds, we felt a shift: growing appetite for more advanced use cases. On-chain options and structured products (historically slower to gain traction) are getting real attention with platforms like Enzyme.Myso and Panoptic taking the stage.\n\nBig thanks to everyone who made the week so energizing. See you in the next one! 👋",
"url": "https://www.linkedin.com/posts/enzymefinance_back-from-ethcc-and-still-thinking-about-activity-7346875443519590402-YC1H"
},
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Enzyme",
"url": "https://www.linkedin.com/company/enzymefinance",
"description": "Enzyme provides industry leaders with a comprehensive infrastructure to manage on-chain assets efficiently, optimize operational processes, and develop innovative financial strategies tailored to their unique goals and challenges",
"numberOfEmployees": {
"value": 17,
"@type": "QuantitativeValue"
},
"logo": {
"contentUrl": "https://media.licdn.com/dms/image/v2/D4E0BAQHl8xHN_v5A_w/company-logo_200_200/B4EZY0LJThHUAQ-/0/1744632059479/enzymefinance_logo?e=2147483647&v=beta&t=OA2uR1-rGgAeJCbBd7HHeYb1FYQaRPr5jc8tpjhNBC0",
"description": "Enzyme",
"@type": "ImageObject"
},
"slogan": "The global infrastructure for tokenized finance.",
"sameAs": "https://enzyme.finance"
}
]
}© 2025. I hope you have a nice day.